Liver Cancer Translational Research Group, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain.
Gastrointestinal and Pancreatic Oncology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.
Clin Cancer Res. 2020 Dec 1;26(23):6350-6361. doi: 10.1158/1078-0432.CCR-20-1497. Epub 2020 Sep 1.
Chromosomal instability is a hallmark of cancer that results in broad and focal copy-number alterations (CNAs), two events associated with distinct molecular, immunologic, and clinical features. In hepatocellular carcinoma (HCC), the role of CNAs has not been thoroughly assessed. Thus, we dissected the impact of CNA burdens on HCC molecular and immune features.
We analyzed SNP array data from 452 paired tumor/adjacent resected HCCs and 25 dysplastic nodules. For each sample, broad and focal CNA burdens were quantified using CNApp, and the resulting broad scores (BS) and focal scores (FS) were correlated with transcriptomic, mutational, and methylation profiles, tumor immune composition, and clinicopathologic data.
HCCs with low broad CNA burdens (defined as BS ≤ 4; 17%) presented high inflammation, active infiltrate signaling, high cytolytic activity, and enrichment of the "HCC immune class" and gene signatures related to antigen presentation. Conversely, tumors with chromosomal instability (high broad CNA loads, BS ≥ 11; 40%), displayed immune-excluded traits and were linked to proliferation, dysfunction, and DNA repair. Candidate determinants of the low cytotoxicity and immune exclusion features of high-BS tumors included alterations in antigen-presenting machinery (i.e., HLA), widespread hypomethylation, and decreased rates of observed/expected neoantigenic mutations. High FSs were independent of tumor immune features, but were related to proliferation, dysfunction, and progenitor cell traits.
HCCs with high chromosomal instability exhibit features of immune exclusion, whereas tumors displaying low burdens of broad CNAs present an immune active profile. These CNA scores can be tested to predict response to immunotherapies.
染色体不稳定性是癌症的一个标志,导致广泛和局灶性拷贝数改变(CNAs),这两个事件与不同的分子、免疫和临床特征相关。在肝细胞癌(HCC)中,CNAs 的作用尚未得到充分评估。因此,我们剖析了 CNA 负担对 HCC 分子和免疫特征的影响。
我们分析了来自 452 对肿瘤/相邻切除 HCC 和 25 个异型增生结节的 SNP 阵列数据。对于每个样本,使用 CNApp 量化广泛和局灶性 CNA 负担,所得的广泛评分(BS)和局灶评分(FS)与转录组、突变和甲基化谱、肿瘤免疫组成和临床病理数据相关。
低广泛 CNA 负担(定义为 BS ≤ 4;17%)的 HCC 表现出高炎症、活跃浸润信号、高细胞毒性活性,并且富集了“HCC 免疫类”和与抗原呈递相关的基因特征。相反,染色体不稳定(高广泛 CNA 负荷,BS ≥ 11;40%)的肿瘤表现出免疫排斥特征,与增殖、功能障碍和 DNA 修复有关。高 BS 肿瘤低细胞毒性和免疫排斥特征的候选决定因素包括抗原呈递机制(即 HLA)的改变、广泛的低甲基化和观察到的/预期的新抗原突变率降低。高 FS 与肿瘤免疫特征无关,但与增殖、功能障碍和祖细胞特征有关。
高染色体不稳定性的 HCC 表现出免疫排斥特征,而显示低广泛 CNA 负担的肿瘤呈现出免疫活跃的特征。这些 CNA 评分可用于预测对免疫疗法的反应。